COMP <GO>
ACB vs NAGE // FREE CASH FLOW YIELD
Aurora Cannabis Inc. (NASDAQ) VS. Niagen Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: ACB 2
— NAGE 0
■ METRIC PARITY
LAST: $4.08 (0.00%) • MKT CAP: $252.8M
fcf-yield
—
LAST: $2.50 (-1.57%) • MKT CAP: $197.8M
fcf-yield
6.83%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACB VS. NAGE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACB | NAGE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 64.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 16.80% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 12.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | 6.83% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 12.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 13.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 29.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.40 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 7/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.2 | 30.2 | +19.95 | ACB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 9.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $252.8M | $197.8M | $55.0M | ACB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACB REV | NAGE REV | ACB GROSS % | NAGE GROSS % | ACB FCF | NAGE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $129.4M | — | 64.3% | — | $13.5M |
| FY 2024 | — | $99.6M | — | 61.8% | — | $12.1M |
| FY 2023 | — | $83.6M | — | — | — | $7.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACB // BETA —
NAGE // BETA —